Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
In Briefs

Pediatric Hematopoietic Stem Cell Transplant

Ellen Fraint, Mary Jo Holuba and Lisa Wray
Pediatrics in Review November 2020, 41 (11) 609-611; DOI: https://doi.org/10.1542/pir.2020-0130
Ellen Fraint
*Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children’s Hospital at Montefiore, Bronx, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Jo Holuba
*Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children’s Hospital at Montefiore, Bronx, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Wray
†Division of Oncology, Children’s Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF
  1. Ellen Fraint, MD*
  2. Mary Jo Holuba, MSN, CPNP*
  3. Lisa Wray, MD†
  1. *Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children’s Hospital at Montefiore, Bronx, NY
  2. †Division of Oncology, Children’s Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Hematopoietic stem cell transplant (HSCT) has emerged during the past 6 decades as an increasingly successful option to cure a variety of malignant and nonmalignant disorders in children. HSCT has been performed in humans since the late 1950s, with significant success first noted in the 1970s. At that time, indications for transplant began to expand beyond malignancies and some bone marrow failure disorders: the scope of pediatric diseases treatable by HSCT now includes, in addition to malignant disorders such as high-risk acute leukemias and solid tumors, a wide range of hereditary conditions, including storage and metabolic disorders, hemoglobinopathies, and immune deficiencies (Table).

View this table:
  • In this window
  • In a new window
Table.

Indications for HSCT in Pediatrics

Posttransplant survival in pediatric patients has continuously improved over time from a combination of refined approaches to patient selection, conditioning, and improved supportive care. For example, 5-year survival after a matched sibling donor transplant for pediatric acute lymphoblastic leukemia is now 70%, a remarkable achievement over only a few decades of experience.

Improvements in HSCT outcomes are not limited to the care of children with malignancies; they are noted across the breadth of indications for the procedure. For example, newborn screening programs now identify babies with X-linked adrenoleukodystrophy or severe combined immunodeficiency, enabling rapid referrals for HSCT before the onset of symptoms. Performing HSCT urgently in such patients has led to durable cures with excellent long-term outcomes before patients develop sequelae of their hereditary diseases.

In patients with hematologic malignancy, the indications for transplant have evolved over time, as survival rates with chemotherapy alone have risen and the ability to stratify patients into risk categories has improved with advanced molecular diagnostic tools. Overall survival for pediatric acute lymphoblastic leukemia (ALL), for example, is greater than 90%, and recent clinical trials aim to maintain excellent outcomes while decreasing exposure to chemotherapy and its …

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics in Review: 41 (11)
Pediatrics in Review
Vol. 41, Issue 11
1 Nov 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pediatric Hematopoietic Stem Cell Transplant
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Pediatric Hematopoietic Stem Cell Transplant
Ellen Fraint, Mary Jo Holuba, Lisa Wray
Pediatrics in Review Nov 2020, 41 (11) 609-611; DOI: 10.1542/pir.2020-0130

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pediatric Hematopoietic Stem Cell Transplant
Ellen Fraint, Mary Jo Holuba, Lisa Wray
Pediatrics in Review Nov 2020, 41 (11) 609-611; DOI: 10.1542/pir.2020-0130
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Footnotes
    • Suggested Reading
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diaper Dermatitis
  • Treatment of Gastroesophageal Reflux Disease in Children
  • Imaging the Infant or Child with an Abnormal Head Circumference
Show more In Briefs

Similar Articles

Subjects

  • Hematology/Oncology
    • Blood Disorders
    • Cancer/Neoplastic
  • Journal Info
  • Editorial Board
  • ABP Content Specifications Map
  • Overview
  • Licensing Information
  • Authors
  • Author Guidelines
  • Submit My Manuscript
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
American Academy of Pediatrics

© 2021 American Academy of Pediatrics